Toll Brothers (TOL) Q3 2026 (USD): EPS 2.97 (exp. 2.90), revenue 2.66bln (exp. 2.60bln). Raises buyback by USD 50mln
Newsquawk Staff ·
Toll Brothers (TOL) Q3 2026 (USD): EPS 2.97 (exp. 2.90), revenue 2.66bln (exp. 2.60bln). Raises buyback by USD 50mln.
What it means
A modest beat on both lines with a buyback top-up is the standard pattern for homebuilders in the current cycle: earnings surprises at this group have repeatedly been driven less by volume than by gross margin on delivered homes and by the pace of land and spec inventory turns, so the margin line and any commentary on incentives and mortgage rate buydowns carry more weight than the headline EPS gap. Capital returns of this size are a recurring feature of the sector, where builders have historically run asset-light, cash-generative models and recycled that cash into repurchases, and incremental authorisations have typically been read as a signal of management comfort with backlog conversion rather than a standalone catalyst. The peers in the luxury and move-up segment have tended to trade as a block on each other's prints, so the read-across to the rest of the building complex usually matters as much as the single-name reaction. What follows the release is the call: orders, cancellation rates, and community count guidance have been the swing factors in past quarters, and any update there sets the tone for the group into the next reporting round. Beats of this magnitude have historically faded unless accompanied by forward order strength.
Sources
- Instacart (CART) is reportedly exploring a sale, The Information reports; held talks with DoorDash (DASH) and Uber (UBER)
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
Related headlines
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL3 hours ago
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th3 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS4 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 20274 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system4 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter5 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 5 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability5 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine5 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)6 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed6 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce7 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders7 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer7 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation8 hours ago